What is the main neurotransmitter abnormality in Tourette's?

A. Dopamine. Tourette’s syndrome is primarily associated with dopamine dysregulation, particularly increased dopamine activity in the basal ganglia. This overactivity leads to excessive, involuntary motor and vocal tics. Dopamine-blocking medications, such as antipsychotics (e.g., haloperidol, risperidone), can help reduce tic severity. B. Serotonin. While serotonin plays a role in mood regulation and impulse control, it is not the primary neurotransmitter involved in Tourette’s. However, selective serotonin reuptake inhibitors (SSRIs) may be used to treat co-occurring obsessive-compulsive disorder (OCD) and anxiety symptoms in Tourette’s patients. C. Glutamate is the brain’s primary excitatory neurotransmitter, involved in learning and memory. While some research suggests glutamate imbalances may contribute to tic severity and compulsive behaviors, dopamine remains the key neurotransmitter in Tourette’s pathology. D. GABA is the brain’s primary inhibitory neurotransmitter, responsible for reducing neural excitability. Though impaired GABAergic inhibition may contribute to tic generation, the main abnormality in Tourette’s involves dopamine overactivity in the basal ganglia and cortico-striatal-thalamo-cortical circuits.